COLA: Drug Challenges and Desensitization
Evaluation of drug allergy is difficult. Clinical presentation is heterogeneous and can mimic many different pathophysiologic events. Poor diagnostic techniques exist and patient history is often remote and poorly documented.
Session recorded on: August 3, 2018
Speaker: Rebecca Saff, MD
Price: FREE for members, $35 non-members
Viewers can earn credit by completing the posttest questions.
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support
There is no commercial support for this activity.
Target Audience
Practicing allergists/immunologists
Fellows-in-Training
Learning Objectives
- Discuss how to evaluate and manage patients with drug hypersensitivity reactions
- Discuss diagnostic strategies of drug allergy (including skin testing, desensitization, drug challenge) and understand when each is appropriate
- Review specific drug allergy scenarios for penicillin, NSAIDs, and chemotherapy
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support
There is no commercial support for this activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance